News
Eli Lilly and Novo Nordisk dominate the billion-dollar weight loss drug market. Lilly has announced positive trial results ...
Bullish option flow detected in Recursion Pharmaceuticals (RXRX) with 9,589 calls trading, 1.6x expected, and implied vol increasing over 27 points to 135.16%. Jan-26 10 calls and 4/11 weekly 6 ...
Hosted on MSN15d
Proposed tariffs on pharmaceuticals could significantly raise drug, health care costsThe impact of those Chinese tariffs could be significant on generic drugs, which make up about 90% of medicines prescribed in America, and most of the ingredients are made in China and India ...
President Donald Trump says he plans to impose tariffs on pharmaceuticals "very shortly," in what could be the next phase of his sweeping overhaul of global trade. President Donald Trump says he ...
Checkmate Pharmaceuticals, Takeda, Genocea Biosciences, NeoImmuneTech, Sensei Biotherapeutics, among others. Metastatic Merkel Cell Carcinoma Market Metastatic Merkel Cell Carcinoma Market ...
Checkmate Pharmaceuticals, Takeda, Genocea Biosciences, NeoImmuneTech, Sensei Biotherapeutics, among others. Metastatic Merkel Cell Carcinoma Pipeline Insight - 2025 report provides comprehensive ...
While the omission of pharmaceuticals from President Donald Trump’s much-anticipated reciprocal tariffs gave the industry a momentary reprieve, renewed threats of drug duties—which have ...
Checkmate Pharmaceuticals, Takeda, Genocea Biosciences, NeoImmuneTech, Sensei Biotherapeutics, among others. Metastatic Merkel Cell Carcinoma Pipeline Insight – 2025 report provides ...
Global drugmakers’ stocks dropped across the board today after U.S. President Donald Trump reiterated plans for a “major” tariff on pharmaceutical imports, threatening an interwoven supply ...
President Trump on Tuesday said he’s planning soon to announce “a major tariff on pharmaceuticals,” which were exempted from the new levies he imposed this month. Trump didn’t offer any ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results